nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Conjunctivitis—Acitretin—psoriasis	0.0081	0.0081	CcSEcCtD
Bretylium—Hiccups—Cyclosporine—psoriasis	0.00793	0.00793	CcSEcCtD
Bretylium—Hiccups—Mycophenolate mofetil—psoriasis	0.00773	0.00773	CcSEcCtD
Bretylium—Vertigo—Methoxsalen—psoriasis	0.00738	0.00738	CcSEcCtD
Bretylium—Hiccups—Prednisolone—psoriasis	0.00721	0.00721	CcSEcCtD
Bretylium—Hiccups—Hydrocortisone—psoriasis	0.00705	0.00705	CcSEcCtD
Bretylium—Affect lability—Mycophenolic acid—psoriasis	0.007	0.007	CcSEcCtD
Bretylium—Psychotic disorder—Mycophenolic acid—psoriasis	0.00695	0.00695	CcSEcCtD
Bretylium—Flushing—Acitretin—psoriasis	0.00694	0.00694	CcSEcCtD
Bretylium—Mood swings—Mycophenolic acid—psoriasis	0.00674	0.00674	CcSEcCtD
Bretylium—Hiccups—Triamcinolone—psoriasis	0.00663	0.00663	CcSEcCtD
Bretylium—Orthostatic hypotension—Mycophenolic acid—psoriasis	0.0065	0.0065	CcSEcCtD
Bretylium—Hypertension—Calcitriol—psoriasis	0.00632	0.00632	CcSEcCtD
Bretylium—Anxiety—Calcitriol—psoriasis	0.00621	0.00621	CcSEcCtD
Bretylium—Hiccups—Betamethasone—psoriasis	0.00602	0.00602	CcSEcCtD
Bretylium—Hiccups—Dexamethasone—psoriasis	0.00602	0.00602	CcSEcCtD
Bretylium—Angina pectoris—Mycophenolic acid—psoriasis	0.00599	0.00599	CcSEcCtD
Bretylium—Lethargy—Cyclosporine—psoriasis	0.00587	0.00587	CcSEcCtD
Bretylium—Vertigo—Fluocinolone Acetonide—psoriasis	0.00584	0.00584	CcSEcCtD
Bretylium—Dizziness—Beclomethasone—psoriasis	0.00567	0.00567	CcSEcCtD
Bretylium—Affect lability—Cyclosporine—psoriasis	0.00566	0.00566	CcSEcCtD
Bretylium—Dizziness—Fluocinonide—psoriasis	0.00562	0.00562	CcSEcCtD
Bretylium—Anxiety—Acitretin—psoriasis	0.00553	0.00553	CcSEcCtD
Bretylium—Feeling abnormal—Methoxsalen—psoriasis	0.00553	0.00553	CcSEcCtD
Bretylium—Affect lability—Mycophenolate mofetil—psoriasis	0.00553	0.00553	CcSEcCtD
Bretylium—Psychotic disorder—Mycophenolate mofetil—psoriasis	0.00548	0.00548	CcSEcCtD
Bretylium—Mood swings—Cyclosporine—psoriasis	0.00545	0.00545	CcSEcCtD
Bretylium—Conjunctivitis—Mycophenolic acid—psoriasis	0.00533	0.00533	CcSEcCtD
Bretylium—Mood swings—Mycophenolate mofetil—psoriasis	0.00532	0.00532	CcSEcCtD
Bretylium—Body temperature increased—Methoxsalen—psoriasis	0.0053	0.0053	CcSEcCtD
Bretylium—Hiccups—Prednisone—psoriasis	0.00524	0.00524	CcSEcCtD
Bretylium—Lethargy—Hydrocortisone—psoriasis	0.00522	0.00522	CcSEcCtD
Bretylium—Affect lability—Prednisolone—psoriasis	0.00515	0.00515	CcSEcCtD
Bretylium—Hyperhidrosis—Acitretin—psoriasis	0.00514	0.00514	CcSEcCtD
Bretylium—Orthostatic hypotension—Mycophenolate mofetil—psoriasis	0.00513	0.00513	CcSEcCtD
Bretylium—Nausea—Beclomethasone—psoriasis	0.00509	0.00509	CcSEcCtD
Bretylium—Affect lability—Hydrocortisone—psoriasis	0.00503	0.00503	CcSEcCtD
Bretylium—Bradycardia—Mycophenolic acid—psoriasis	0.00501	0.00501	CcSEcCtD
Bretylium—Psychotic disorder—Hydrocortisone—psoriasis	0.00499	0.00499	CcSEcCtD
Bretylium—Mood swings—Prednisolone—psoriasis	0.00496	0.00496	CcSEcCtD
Bretylium—Gastrointestinal pain—Calcitriol—psoriasis	0.00489	0.00489	CcSEcCtD
Bretylium—Sweating increased—Cyclosporine—psoriasis	0.00484	0.00484	CcSEcCtD
Bretylium—Mood swings—Hydrocortisone—psoriasis	0.00484	0.00484	CcSEcCtD
Bretylium—Affect lability—Triamcinolone—psoriasis	0.00474	0.00474	CcSEcCtD
Bretylium—Angina pectoris—Mycophenolate mofetil—psoriasis	0.00473	0.00473	CcSEcCtD
Bretylium—Body temperature increased—Calcitriol—psoriasis	0.00472	0.00472	CcSEcCtD
Bretylium—Abdominal pain—Calcitriol—psoriasis	0.00472	0.00472	CcSEcCtD
Bretylium—Mood swings—Triamcinolone—psoriasis	0.00456	0.00456	CcSEcCtD
Bretylium—Lethargy—Betamethasone—psoriasis	0.00446	0.00446	CcSEcCtD
Bretylium—Lethargy—Dexamethasone—psoriasis	0.00446	0.00446	CcSEcCtD
Bretylium—Dizziness—Methoxsalen—psoriasis	0.00443	0.00443	CcSEcCtD
Bretylium—Sweating increased—Prednisolone—psoriasis	0.00441	0.00441	CcSEcCtD
Bretylium—Feeling abnormal—Acitretin—psoriasis	0.00438	0.00438	CcSEcCtD
Bretylium—Gastrointestinal pain—Acitretin—psoriasis	0.00435	0.00435	CcSEcCtD
Bretylium—Conjunctivitis—Cyclosporine—psoriasis	0.00431	0.00431	CcSEcCtD
Bretylium—Sweating increased—Hydrocortisone—psoriasis	0.00431	0.00431	CcSEcCtD
Bretylium—Affect lability—Betamethasone—psoriasis	0.0043	0.0043	CcSEcCtD
Bretylium—Affect lability—Dexamethasone—psoriasis	0.0043	0.0043	CcSEcCtD
Bretylium—Psychotic disorder—Betamethasone—psoriasis	0.00427	0.00427	CcSEcCtD
Bretylium—Psychotic disorder—Dexamethasone—psoriasis	0.00427	0.00427	CcSEcCtD
Bretylium—Conjunctivitis—Mycophenolate mofetil—psoriasis	0.0042	0.0042	CcSEcCtD
Bretylium—Body temperature increased—Acitretin—psoriasis	0.0042	0.0042	CcSEcCtD
Bretylium—Abdominal pain—Acitretin—psoriasis	0.0042	0.0042	CcSEcCtD
Bretylium—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.00419	0.00419	CcSEcCtD
Bretylium—Mood swings—Betamethasone—psoriasis	0.00414	0.00414	CcSEcCtD
Bretylium—Mood swings—Dexamethasone—psoriasis	0.00414	0.00414	CcSEcCtD
Bretylium—Diarrhoea—Calcitriol—psoriasis	0.00409	0.00409	CcSEcCtD
Bretylium—Sweating increased—Triamcinolone—psoriasis	0.00405	0.00405	CcSEcCtD
Bretylium—Nausea—Methoxsalen—psoriasis	0.00398	0.00398	CcSEcCtD
Bretylium—Bradycardia—Mycophenolate mofetil—psoriasis	0.00395	0.00395	CcSEcCtD
Bretylium—Conjunctivitis—Prednisolone—psoriasis	0.00392	0.00392	CcSEcCtD
Bretylium—Lethargy—Prednisone—psoriasis	0.00388	0.00388	CcSEcCtD
Bretylium—Vertigo—Mycophenolic acid—psoriasis	0.00385	0.00385	CcSEcCtD
Bretylium—Syncope—Mycophenolic acid—psoriasis	0.00384	0.00384	CcSEcCtD
Bretylium—Vomiting—Calcitriol—psoriasis	0.0038	0.0038	CcSEcCtD
Bretylium—Loss of consciousness—Mycophenolic acid—psoriasis	0.00376	0.00376	CcSEcCtD
Bretylium—Affect lability—Prednisone—psoriasis	0.00375	0.00375	CcSEcCtD
Bretylium—Dyspnoea—Hydroxyurea—psoriasis	0.00372	0.00372	CcSEcCtD
Bretylium—Psychotic disorder—Prednisone—psoriasis	0.00372	0.00372	CcSEcCtD
Bretylium—Hypertension—Mycophenolic acid—psoriasis	0.0037	0.0037	CcSEcCtD
Bretylium—Flushing—Cyclosporine—psoriasis	0.00369	0.00369	CcSEcCtD
Bretylium—Bradycardia—Prednisolone—psoriasis	0.00369	0.00369	CcSEcCtD
Bretylium—Sweating increased—Betamethasone—psoriasis	0.00368	0.00368	CcSEcCtD
Bretylium—Sweating increased—Dexamethasone—psoriasis	0.00368	0.00368	CcSEcCtD
Bretylium—Diarrhoea—Acitretin—psoriasis	0.00364	0.00364	CcSEcCtD
Bretylium—Anxiety—Mycophenolic acid—psoriasis	0.00363	0.00363	CcSEcCtD
Bretylium—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00363	0.00363	CcSEcCtD
Bretylium—Conjunctivitis—Triamcinolone—psoriasis	0.00361	0.00361	CcSEcCtD
Bretylium—Mood swings—Prednisone—psoriasis	0.0036	0.0036	CcSEcCtD
Bretylium—Bradycardia—Hydrocortisone—psoriasis	0.0036	0.0036	CcSEcCtD
Bretylium—Nausea—Calcitriol—psoriasis	0.00355	0.00355	CcSEcCtD
Bretylium—Confusional state—Mycophenolic acid—psoriasis	0.00352	0.00352	CcSEcCtD
Bretylium—Dizziness—Acitretin—psoriasis	0.00352	0.00352	CcSEcCtD
Bretylium—Dizziness—Fluocinolone Acetonide—psoriasis	0.00351	0.00351	CcSEcCtD
Bretylium—Feeling abnormal—Hydroxyurea—psoriasis	0.00344	0.00344	CcSEcCtD
Bretylium—Shock—Mycophenolic acid—psoriasis	0.00344	0.00344	CcSEcCtD
Bretylium—Bradycardia—Triamcinolone—psoriasis	0.00339	0.00339	CcSEcCtD
Bretylium—Vomiting—Acitretin—psoriasis	0.00338	0.00338	CcSEcCtD
Bretylium—Hyperhidrosis—Mycophenolic acid—psoriasis	0.00338	0.00338	CcSEcCtD
Bretylium—Vomiting—Fluocinolone Acetonide—psoriasis	0.00337	0.00337	CcSEcCtD
Bretylium—Body temperature increased—Hydroxyurea—psoriasis	0.0033	0.0033	CcSEcCtD
Bretylium—Conjunctivitis—Dexamethasone—psoriasis	0.00327	0.00327	CcSEcCtD
Bretylium—Conjunctivitis—Betamethasone—psoriasis	0.00327	0.00327	CcSEcCtD
Bretylium—Lethargy—Methotrexate—psoriasis	0.00324	0.00324	CcSEcCtD
Bretylium—Sweating increased—Prednisone—psoriasis	0.0032	0.0032	CcSEcCtD
Bretylium—Nausea—Acitretin—psoriasis	0.00316	0.00316	CcSEcCtD
Bretylium—Nausea—Fluocinolone Acetonide—psoriasis	0.00315	0.00315	CcSEcCtD
Bretylium—Dyspnoea—Mycophenolic acid—psoriasis	0.00312	0.00312	CcSEcCtD
Bretylium—Vertigo—Cyclosporine—psoriasis	0.00311	0.00311	CcSEcCtD
Bretylium—Bradycardia—Dexamethasone—psoriasis	0.00308	0.00308	CcSEcCtD
Bretylium—Bradycardia—Betamethasone—psoriasis	0.00308	0.00308	CcSEcCtD
Bretylium—Vertigo—Mycophenolate mofetil—psoriasis	0.00304	0.00304	CcSEcCtD
Bretylium—Syncope—Mycophenolate mofetil—psoriasis	0.00303	0.00303	CcSEcCtD
Bretylium—Mood swings—Methotrexate—psoriasis	0.00301	0.00301	CcSEcCtD
Bretylium—Hypertension—Cyclosporine—psoriasis	0.00299	0.00299	CcSEcCtD
Bretylium—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00297	0.00297	CcSEcCtD
Bretylium—Anxiety—Cyclosporine—psoriasis	0.00294	0.00294	CcSEcCtD
Bretylium—Hypertension—Mycophenolate mofetil—psoriasis	0.00292	0.00292	CcSEcCtD
Bretylium—Feeling abnormal—Mycophenolic acid—psoriasis	0.00288	0.00288	CcSEcCtD
Bretylium—Anxiety—Mycophenolate mofetil—psoriasis	0.00287	0.00287	CcSEcCtD
Bretylium—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.00286	0.00286	CcSEcCtD
Bretylium—Diarrhoea—Hydroxyurea—psoriasis	0.00286	0.00286	CcSEcCtD
Bretylium—Confusional state—Cyclosporine—psoriasis	0.00285	0.00285	CcSEcCtD
Bretylium—Vertigo—Prednisolone—psoriasis	0.00283	0.00283	CcSEcCtD
Bretylium—Syncope—Prednisolone—psoriasis	0.00283	0.00283	CcSEcCtD
Bretylium—Confusional state—Mycophenolate mofetil—psoriasis	0.00278	0.00278	CcSEcCtD
Bretylium—Loss of consciousness—Prednisolone—psoriasis	0.00277	0.00277	CcSEcCtD
Bretylium—Vertigo—Hydrocortisone—psoriasis	0.00277	0.00277	CcSEcCtD
Bretylium—Abdominal pain—Mycophenolic acid—psoriasis	0.00276	0.00276	CcSEcCtD
Bretylium—Body temperature increased—Mycophenolic acid—psoriasis	0.00276	0.00276	CcSEcCtD
Bretylium—Syncope—Hydrocortisone—psoriasis	0.00276	0.00276	CcSEcCtD
Bretylium—Dizziness—Hydroxyurea—psoriasis	0.00276	0.00276	CcSEcCtD
Bretylium—Hyperhidrosis—Cyclosporine—psoriasis	0.00273	0.00273	CcSEcCtD
Bretylium—Hypertension—Prednisolone—psoriasis	0.00272	0.00272	CcSEcCtD
Bretylium—Shock—Mycophenolate mofetil—psoriasis	0.00271	0.00271	CcSEcCtD
Bretylium—Loss of consciousness—Hydrocortisone—psoriasis	0.00271	0.00271	CcSEcCtD
Bretylium—Bradycardia—Prednisone—psoriasis	0.00268	0.00268	CcSEcCtD
Bretylium—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.00267	0.00267	CcSEcCtD
Bretylium—Hypertension—Hydrocortisone—psoriasis	0.00266	0.00266	CcSEcCtD
Bretylium—Vomiting—Hydroxyurea—psoriasis	0.00265	0.00265	CcSEcCtD
Bretylium—Anxiety—Hydrocortisone—psoriasis	0.00261	0.00261	CcSEcCtD
Bretylium—Vertigo—Triamcinolone—psoriasis	0.00261	0.00261	CcSEcCtD
Bretylium—Syncope—Triamcinolone—psoriasis	0.0026	0.0026	CcSEcCtD
Bretylium—Loss of consciousness—Triamcinolone—psoriasis	0.00255	0.00255	CcSEcCtD
Bretylium—Shock—Prednisolone—psoriasis	0.00253	0.00253	CcSEcCtD
Bretylium—Dyspnoea—Cyclosporine—psoriasis	0.00252	0.00252	CcSEcCtD
Bretylium—Hypertension—Triamcinolone—psoriasis	0.0025	0.0025	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisolone—psoriasis	0.00249	0.00249	CcSEcCtD
Bretylium—Nausea—Hydroxyurea—psoriasis	0.00248	0.00248	CcSEcCtD
Bretylium—Shock—Hydrocortisone—psoriasis	0.00247	0.00247	CcSEcCtD
Bretylium—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00246	0.00246	CcSEcCtD
Bretylium—Flushing—Prednisone—psoriasis	0.00244	0.00244	CcSEcCtD
Bretylium—Hyperhidrosis—Hydrocortisone—psoriasis	0.00243	0.00243	CcSEcCtD
Bretylium—Diarrhoea—Mycophenolic acid—psoriasis	0.00239	0.00239	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—psoriasis	0.00238	0.00238	CcSEcCtD
Bretylium—Vertigo—Dexamethasone—psoriasis	0.00236	0.00236	CcSEcCtD
Bretylium—Vertigo—Betamethasone—psoriasis	0.00236	0.00236	CcSEcCtD
Bretylium—Syncope—Dexamethasone—psoriasis	0.00236	0.00236	CcSEcCtD
Bretylium—Syncope—Betamethasone—psoriasis	0.00236	0.00236	CcSEcCtD
Bretylium—Feeling abnormal—Cyclosporine—psoriasis	0.00233	0.00233	CcSEcCtD
Bretylium—Shock—Triamcinolone—psoriasis	0.00233	0.00233	CcSEcCtD
Bretylium—Gastrointestinal pain—Cyclosporine—psoriasis	0.00231	0.00231	CcSEcCtD
Bretylium—Loss of consciousness—Dexamethasone—psoriasis	0.00231	0.00231	CcSEcCtD
Bretylium—Loss of consciousness—Betamethasone—psoriasis	0.00231	0.00231	CcSEcCtD
Bretylium—Dizziness—Mycophenolic acid—psoriasis	0.00231	0.00231	CcSEcCtD
Bretylium—Hyperhidrosis—Triamcinolone—psoriasis	0.00229	0.00229	CcSEcCtD
Bretylium—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00227	0.00227	CcSEcCtD
Bretylium—Hypertension—Dexamethasone—psoriasis	0.00227	0.00227	CcSEcCtD
Bretylium—Hypertension—Betamethasone—psoriasis	0.00227	0.00227	CcSEcCtD
Bretylium—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00226	0.00226	CcSEcCtD
Bretylium—Abdominal pain—Cyclosporine—psoriasis	0.00224	0.00224	CcSEcCtD
Bretylium—Body temperature increased—Cyclosporine—psoriasis	0.00224	0.00224	CcSEcCtD
Bretylium—Anxiety—Betamethasone—psoriasis	0.00223	0.00223	CcSEcCtD
Bretylium—Anxiety—Dexamethasone—psoriasis	0.00223	0.00223	CcSEcCtD
Bretylium—Vomiting—Mycophenolic acid—psoriasis	0.00222	0.00222	CcSEcCtD
Bretylium—Abdominal pain—Mycophenolate mofetil—psoriasis	0.00218	0.00218	CcSEcCtD
Bretylium—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00218	0.00218	CcSEcCtD
Bretylium—Feeling abnormal—Prednisolone—psoriasis	0.00212	0.00212	CcSEcCtD
Bretylium—Shock—Betamethasone—psoriasis	0.00211	0.00211	CcSEcCtD
Bretylium—Shock—Dexamethasone—psoriasis	0.00211	0.00211	CcSEcCtD
Bretylium—Dyspnoea—Triamcinolone—psoriasis	0.00211	0.00211	CcSEcCtD
Bretylium—Nausea—Mycophenolic acid—psoriasis	0.00208	0.00208	CcSEcCtD
Bretylium—Hyperhidrosis—Betamethasone—psoriasis	0.00208	0.00208	CcSEcCtD
Bretylium—Hyperhidrosis—Dexamethasone—psoriasis	0.00208	0.00208	CcSEcCtD
Bretylium—Feeling abnormal—Hydrocortisone—psoriasis	0.00207	0.00207	CcSEcCtD
Bretylium—Vertigo—Prednisone—psoriasis	0.00206	0.00206	CcSEcCtD
Bretylium—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00206	0.00206	CcSEcCtD
Bretylium—Syncope—Prednisone—psoriasis	0.00205	0.00205	CcSEcCtD
Bretylium—Loss of consciousness—Prednisone—psoriasis	0.00201	0.00201	CcSEcCtD
Bretylium—Abdominal pain—Hydrocortisone—psoriasis	0.00199	0.00199	CcSEcCtD
Bretylium—Body temperature increased—Hydrocortisone—psoriasis	0.00199	0.00199	CcSEcCtD
Bretylium—Hypertension—Prednisone—psoriasis	0.00198	0.00198	CcSEcCtD
Bretylium—Feeling abnormal—Triamcinolone—psoriasis	0.00195	0.00195	CcSEcCtD
Bretylium—Anxiety—Prednisone—psoriasis	0.00194	0.00194	CcSEcCtD
Bretylium—Diarrhoea—Cyclosporine—psoriasis	0.00194	0.00194	CcSEcCtD
Bretylium—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00189	0.00189	CcSEcCtD
Bretylium—Body temperature increased—Triamcinolone—psoriasis	0.00187	0.00187	CcSEcCtD
Bretylium—Dizziness—Cyclosporine—psoriasis	0.00187	0.00187	CcSEcCtD
Bretylium—Shock—Prednisone—psoriasis	0.00184	0.00184	CcSEcCtD
Bretylium—Dizziness—Mycophenolate mofetil—psoriasis	0.00182	0.00182	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisone—psoriasis	0.00181	0.00181	CcSEcCtD
Bretylium—Vomiting—Cyclosporine—psoriasis	0.0018	0.0018	CcSEcCtD
Bretylium—Feeling abnormal—Betamethasone—psoriasis	0.00177	0.00177	CcSEcCtD
Bretylium—Feeling abnormal—Dexamethasone—psoriasis	0.00177	0.00177	CcSEcCtD
Bretylium—Gastrointestinal pain—Dexamethasone—psoriasis	0.00176	0.00176	CcSEcCtD
Bretylium—Gastrointestinal pain—Betamethasone—psoriasis	0.00176	0.00176	CcSEcCtD
Bretylium—Vomiting—Mycophenolate mofetil—psoriasis	0.00175	0.00175	CcSEcCtD
Bretylium—Vertigo—Methotrexate—psoriasis	0.00172	0.00172	CcSEcCtD
Bretylium—Diarrhoea—Hydrocortisone—psoriasis	0.00172	0.00172	CcSEcCtD
Bretylium—Dizziness—Prednisolone—psoriasis	0.0017	0.0017	CcSEcCtD
Bretylium—Abdominal pain—Betamethasone—psoriasis	0.0017	0.0017	CcSEcCtD
Bretylium—Abdominal pain—Dexamethasone—psoriasis	0.0017	0.0017	CcSEcCtD
Bretylium—Body temperature increased—Betamethasone—psoriasis	0.0017	0.0017	CcSEcCtD
Bretylium—Body temperature increased—Dexamethasone—psoriasis	0.0017	0.0017	CcSEcCtD
Bretylium—Nausea—Cyclosporine—psoriasis	0.00168	0.00168	CcSEcCtD
Bretylium—Dizziness—Hydrocortisone—psoriasis	0.00166	0.00166	CcSEcCtD
Bretylium—Nausea—Mycophenolate mofetil—psoriasis	0.00164	0.00164	CcSEcCtD
Bretylium—Vomiting—Hydrocortisone—psoriasis	0.0016	0.0016	CcSEcCtD
Bretylium—Confusional state—Methotrexate—psoriasis	0.00158	0.00158	CcSEcCtD
Bretylium—Dizziness—Triamcinolone—psoriasis	0.00157	0.00157	CcSEcCtD
Bretylium—Feeling abnormal—Prednisone—psoriasis	0.00154	0.00154	CcSEcCtD
Bretylium—Gastrointestinal pain—Prednisone—psoriasis	0.00153	0.00153	CcSEcCtD
Bretylium—Nausea—Prednisolone—psoriasis	0.00153	0.00153	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—psoriasis	0.00151	0.00151	CcSEcCtD
Bretylium—Vomiting—Triamcinolone—psoriasis	0.0015	0.0015	CcSEcCtD
Bretylium—Nausea—Hydrocortisone—psoriasis	0.00149	0.00149	CcSEcCtD
Bretylium—Abdominal pain—Prednisone—psoriasis	0.00148	0.00148	CcSEcCtD
Bretylium—Body temperature increased—Prednisone—psoriasis	0.00148	0.00148	CcSEcCtD
Bretylium—Diarrhoea—Betamethasone—psoriasis	0.00147	0.00147	CcSEcCtD
Bretylium—Diarrhoea—Dexamethasone—psoriasis	0.00147	0.00147	CcSEcCtD
Bretylium—Dizziness—Betamethasone—psoriasis	0.00142	0.00142	CcSEcCtD
Bretylium—Dizziness—Dexamethasone—psoriasis	0.00142	0.00142	CcSEcCtD
Bretylium—Nausea—Triamcinolone—psoriasis	0.00141	0.00141	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—psoriasis	0.00139	0.00139	CcSEcCtD
Bretylium—Vomiting—Dexamethasone—psoriasis	0.00137	0.00137	CcSEcCtD
Bretylium—Vomiting—Betamethasone—psoriasis	0.00137	0.00137	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—psoriasis	0.00129	0.00129	CcSEcCtD
Bretylium—Diarrhoea—Prednisone—psoriasis	0.00128	0.00128	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—psoriasis	0.00128	0.00128	CcSEcCtD
Bretylium—Nausea—Dexamethasone—psoriasis	0.00128	0.00128	CcSEcCtD
Bretylium—Nausea—Betamethasone—psoriasis	0.00128	0.00128	CcSEcCtD
Bretylium—Dizziness—Prednisone—psoriasis	0.00124	0.00124	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—psoriasis	0.00124	0.00124	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—psoriasis	0.00124	0.00124	CcSEcCtD
Bretylium—Vomiting—Prednisone—psoriasis	0.00119	0.00119	CcSEcCtD
Bretylium—Nausea—Prednisone—psoriasis	0.00111	0.00111	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—psoriasis	0.00107	0.00107	CcSEcCtD
Bretylium—Dizziness—Methotrexate—psoriasis	0.00103	0.00103	CcSEcCtD
Bretylium—Vomiting—Methotrexate—psoriasis	0.000994	0.000994	CcSEcCtD
Bretylium—Nausea—Methotrexate—psoriasis	0.000928	0.000928	CcSEcCtD
